These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
196 related articles for article (PubMed ID: 33424832)
21. The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro. Sui H; Tan H; Fu J; Song Q; Jia R; Han L; Lv Y; Zhang H; Zheng D; Dong L; Wang S; Li Q; Xu H FASEB J; 2020 Jun; 34(6):7387-7403. PubMed ID: 32283574 [TBL] [Abstract][Full Text] [Related]
22. Expression of NK cell receptor ligands in primary colorectal cancer tissue in relation to the phenotype of circulating NK- and NKT cells, and clinical outcome. Krijgsman D; Roelands J; Andersen MN; Wieringa CHLA; Tollenaar RAEM; Hendrickx W; Bedognetti D; Hokland M; Kuppen PJK Mol Immunol; 2020 Dec; 128():205-218. PubMed ID: 33142138 [TBL] [Abstract][Full Text] [Related]
23. Differences in circulating lymphocyte subpopulations among patients with inflammatory polyps, colorectal adenomas and colorectal cancer. Zheng J; Jin H; Tu Y Arab J Gastroenterol; 2024 May; 25(2):129-134. PubMed ID: 38413325 [TBL] [Abstract][Full Text] [Related]
24. Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer. Shen Y; Wang Q; Qi Y; Cui B; Zhang Z; Su J; Liu X; Lu C; Ye H; Ju Y; Lu Z Mol Med Rep; 2014 Aug; 10(2):977-82. PubMed ID: 24819058 [TBL] [Abstract][Full Text] [Related]
25. Hedyotis diffusa Willd suppresses metastasis in 5‑fluorouracil‑resistant colorectal cancer cells by regulating the TGF‑β signaling pathway. Lai Z; Yan Z; Chen W; Peng J; Feng J; Li Q; Jin Y; Lin J Mol Med Rep; 2017 Nov; 16(5):7752-7758. PubMed ID: 28944846 [TBL] [Abstract][Full Text] [Related]
26. Wnt-driven LARGE2 mediates laminin-adhesive O-glycosylation in human colonic epithelial cells and colorectal cancer. Dietinger V; García de Durango CR; Wiechmann S; Boos SL; Michl M; Neumann J; Hermeking H; Kuster B; Jung P Cell Commun Signal; 2020 Jun; 18(1):102. PubMed ID: 32586342 [TBL] [Abstract][Full Text] [Related]
27. The MUTYH base excision repair gene protects against inflammation-associated colorectal carcinogenesis. Grasso F; Di Meo S; De Luca G; Pasquini L; Rossi S; Boirivant M; Biffoni M; Bignami M; Di Carlo E Oncotarget; 2015 Aug; 6(23):19671-84. PubMed ID: 26109431 [TBL] [Abstract][Full Text] [Related]
28. Colorectal cancer subtyping and immune landscape analysis based on natural killer cell-related genes. Ding M; Gao J; Wang J; Li Z; Gong X; Cui Z; Li C; Xue H; Li D; Wang Y Arab J Gastroenterol; 2024 May; 25(2):150-159. PubMed ID: 38719664 [TBL] [Abstract][Full Text] [Related]
29. The effect of statins in colorectal cancer is mediated through the bone morphogenetic protein pathway. Kodach LL; Bleuming SA; Peppelenbosch MP; Hommes DW; van den Brink GR; Hardwick JC Gastroenterology; 2007 Oct; 133(4):1272-81. PubMed ID: 17919499 [TBL] [Abstract][Full Text] [Related]
30. Association Between Natural Killer Cell Activity and Colorectal Cancer in High-Risk Subjects Undergoing Colonoscopy. Jobin G; Rodriguez-Suarez R; Betito K Gastroenterology; 2017 Oct; 153(4):980-987. PubMed ID: 28625834 [TBL] [Abstract][Full Text] [Related]
31. Bone morphogenetic protein 4 induces differentiation of colorectal cancer stem cells and increases their response to chemotherapy in mice. Lombardo Y; Scopelliti A; Cammareri P; Todaro M; Iovino F; Ricci-Vitiani L; Gulotta G; Dieli F; de Maria R; Stassi G Gastroenterology; 2011 Jan; 140(1):297-309. PubMed ID: 20951698 [TBL] [Abstract][Full Text] [Related]
32. Profiling Activins and Follistatin in Colorectal Cancer According to Clinical Stage, Tumour Sidedness and Smad4 Status. Refaat B; Zekri J; Aslam A; Ahmad J; Baghdadi MA; Meliti A; Idris S; Sultan S; Alardati H; Saimeh HA; Alsaegh A; Alhadrami M; Hamid T; Naeem ME; Elsamany SA Pathol Oncol Res; 2021; 27():1610032. PubMed ID: 34867090 [TBL] [Abstract][Full Text] [Related]
33. Preoperative Tim‑3 expression on peripheral NK cells is correlated with pathologic TNM staging in colorectal cancer. Wang Y; Sun J; Gao W; Song B; Shao Q; Zhao L; Zhang Y; Wang Q; Zhang Y; Qu X Mol Med Rep; 2017 Jun; 15(6):3810-3818. PubMed ID: 28440449 [TBL] [Abstract][Full Text] [Related]
34. Potentiating NK cell activity by combination of Rosuvastatin and Difluoromethylornithine for effective chemopreventive efficacy against Colon Cancer. Janakiram NB; Mohammed A; Bryant T; Zhang Y; Brewer M; Duff A; Biddick L; Singh A; Lightfoot S; Steele VE; Rao CV Sci Rep; 2016 Nov; 6():37046. PubMed ID: 27841323 [TBL] [Abstract][Full Text] [Related]
35. SMAD7 and SMAD4 expression in colorectal cancer progression and therapy response. Rosic J; Dragicevic S; Miladinov M; Despotovic J; Bogdanovic A; Krivokapic Z; Nikolic A Exp Mol Pathol; 2021 Dec; 123():104714. PubMed ID: 34717960 [TBL] [Abstract][Full Text] [Related]
36. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis. Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034 [TBL] [Abstract][Full Text] [Related]
37. Innate tumor killers in colorectal cancer. Zhong F; Lin Y; Jing X; Ye Y; Wang S; Shen Z Cancer Lett; 2022 Feb; 527():115-126. PubMed ID: 34952144 [TBL] [Abstract][Full Text] [Related]
38. Multiomics of Colorectal Cancer Organoids Reveals Putative Mediators of Cancer Progression Resulting from SMAD4 Inactivation. Dijkstra JJ; Neikes HK; Rezaeifard S; Ma X; Voest EE; Tauriello DVF; Vermeulen M J Proteome Res; 2023 Jan; 22(1):138-151. PubMed ID: 36450103 [TBL] [Abstract][Full Text] [Related]
39. Umbilical Cord Blood-Derived Natural Killer Cells Combined with Bevacizumab for Colorectal Cancer Treatment. Xu C; Liu D; Chen Z; Zhuo F; Sun H; Hu J; Li T Hum Gene Ther; 2019 Apr; 30(4):459-470. PubMed ID: 29914273 [TBL] [Abstract][Full Text] [Related]
40. High SMAD4 levels appear in microsatellite instability and hypermethylated colon cancers, and indicate a better prognosis. Isaksson-Mettävainio M; Palmqvist R; Dahlin AM; Van Guelpen B; Rutegård J; Oberg A; Henriksson ML Int J Cancer; 2012 Aug; 131(4):779-88. PubMed ID: 21964812 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]